Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound Guided ESP Block for Rib Fracture Analgesia
NCT04168710Phase 2Withdrawn
- Sponsor
- Yale University
- Start
- May 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine in rib fracture (2 arms), sponsored by Yale University. Primary endpoint: Total intravenous (IV) and oral narcotic analgesic use at 24 hours. Planned start May 2025; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT04168710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04168710.